138 related articles for article (PubMed ID: 26197800)
21. Expression and mutational analysis of c-kit in ovarian surface epithelial tumors.
Kim DJ; Lee MH; Park TI; Bae HI
J Korean Med Sci; 2006 Feb; 21(1):81-5. PubMed ID: 16479070
[TBL] [Abstract][Full Text] [Related]
22. KRAS Mutation in Serous Borderline Tumor of the Testis: Report of a Case and Review of the Literature.
Bouri S; Noël JC; Catteau X; Al Hajj Obeid W; Svistakov I; Roumeguère T; D'Haene N; Rorive S
Case Rep Urol; 2020; 2020():5419707. PubMed ID: 33062370
[TBL] [Abstract][Full Text] [Related]
23. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.
Tan Y; Sinniah R; Bay BH; Singh G
J Pathol; 1999 Sep; 189(1):60-5. PubMed ID: 10451489
[TBL] [Abstract][Full Text] [Related]
24. Mucinous cystadenocarcinoma of the testis: a case report.
Iuga AC; Mull J; Batra R; Miller W
Hum Pathol; 2011 Sep; 42(9):1343-7. PubMed ID: 21396680
[TBL] [Abstract][Full Text] [Related]
25. Paratesticular müllerian-type papillary serous tumor in a child.
Cohen MC; Shawis R; Evans C
Pediatr Dev Pathol; 2009; 12(4):297-300. PubMed ID: 19348511
[TBL] [Abstract][Full Text] [Related]
26. Borderline serous papillary tumor of the testis.
Fonseca D; Manasa PL; Sharma R; Giridhar A
Indian J Pathol Microbiol; 2020; 63(4):618-619. PubMed ID: 33154318
[TBL] [Abstract][Full Text] [Related]
27. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
Agaimy A; Terracciano LM; Dirnhofer S; Tornillo L; Foerster A; Hartmann A; Bihl MP
J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230
[TBL] [Abstract][Full Text] [Related]
28. Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation.
Kim KR; Choi J; Hwang JE; Baik YA; Shim JY; Kim YM; Robboy SJ
Histopathology; 2010 Oct; 57(4):587-96. PubMed ID: 20955384
[TBL] [Abstract][Full Text] [Related]
29. A diagnostic pitfall of fine needle aspiration cytology in testicular papillary serous cyst adenoma: a case report.
Kumar PV; Shirazi M; Salehi M
Acta Cytol; 2009; 53(4):467-70. PubMed ID: 19697740
[TBL] [Abstract][Full Text] [Related]
30. Serous cystadenoma of the epididymis of common epithelial ovarian type: case report with an immunohistochemical study.
Klimis T; Vlahos P; Kokotas N
J BUON; 2006; 11(2):237-40. PubMed ID: 17318978
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic analysis of ovarian and testicular Müllerian papillary serous tumors.
Carano KS; Soslow RA
Mod Pathol; 1997 May; 10(5):414-20. PubMed ID: 9160304
[TBL] [Abstract][Full Text] [Related]
32. Primary signet-ring stromal tumour of the testis: case report with literature review.
Fichtner A; Fisseler-Eckhoff A; Kramer W; Radzun HJ; Ströbel P; Bremmer F
APMIS; 2019 Jan; 127(1):45-49. PubMed ID: 30549139
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical examination of mucinous cystadenoma of the testis.
Naito S; Yamazumi K; Yakata Y; Shono T; Hakariya H; Nakayama T; Nakashima M; Sekine I
Pathol Int; 2004 May; 54(5):355-9. PubMed ID: 15086841
[TBL] [Abstract][Full Text] [Related]
34. Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas.
Hsu CY; Bristow R; Cha MS; Wang BG; Ho CL; Kurman RJ; Wang TL; Shih IeM
Clin Cancer Res; 2004 Oct; 10(19):6432-6. PubMed ID: 15475429
[TBL] [Abstract][Full Text] [Related]
35. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
Mayr D; Hirschmann A; Löhrs U; Diebold J
Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
[TBL] [Abstract][Full Text] [Related]
36. Intratesticular borderline serous tumor.
Abdullah LS; Gupta R; Arnst A
Int J Urol; 2006 Dec; 13(12):1536-8. PubMed ID: 17118032
[TBL] [Abstract][Full Text] [Related]
37. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
[TBL] [Abstract][Full Text] [Related]
38. Intraparenchymal serous papillary cystadenoma of the testis: a case report.
Olla L; Di Naro N; Puliga G; Tolu GA
Pathologica; 2013 Feb; 105(1):15-7. PubMed ID: 23858946
[TBL] [Abstract][Full Text] [Related]
39. Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis.
Dundr P; Gregová M; Němejcová K; Bártů M; Hájková N; Hojný J; Stružinská I; Fischerová D
Diagn Pathol; 2020 Jul; 15(1):91. PubMed ID: 32693840
[TBL] [Abstract][Full Text] [Related]
40. A Case of Paratubal Serous Borderline Tumor Driven by a Somatic BRAF Mutation in an Adolescent Patient.
Chao A; Huang YL; Lin CY; Chao AS; Lee YS; Wu RC; Lai CH
J Pediatr Adolesc Gynecol; 2021 Apr; 34(2):228-230. PubMed ID: 33188936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
